This site uses cookies to ensure the best viewing experience for our readers.
Itamar Medical Closes Nasdaq Public Offering at $40.25 Million

Itamar Medical Closes Nasdaq Public Offering at $40.25 Million

The medical diagnosis company initially looked to raise $30 million to fund its sales and marketing operations as well as product development and clinical trials

CTech | 11:20  05.02.2020
Nasdaq and Tel Aviv-listed medical diagnosis company Itamar Medical Ltd. has closed its public offering of American Depositary Shares (ADS) on Nasdaq at $40.25 million, the company announced Tuesday. The company initially looked to raise $30 million but increased its offering due to demand. The company, which develops and manufactures non-invasive diagnostic devices for sleep disorders and cardiovascular diseases, will use the proceeds for sales and marketing as well as product development and clinical research.

Nasdaq. Photo: Shutterstock Nasdaq. Photo: Shutterstock Nasdaq. Photo: Shutterstock

share on facebook share on twitter share on linkedin share on whatsapp share on mail

TAGS